Your Money with Michelle Martin
About
Your Money With Michelle Martin (9am - 12pm) It’s all about Your Money with Michelle Martin from 9am to 12pm. How to save, invest and make the best financial decisions for yourself. Listen to inspiring thinkers with “Influence” and hear from great authors in “Read”.
SEP 22, 2021
22/09/21 - Money and Me: When old-school money habits meets tech, does it become easier to save?David Fergusson, CEO and Co-Founder of Hugo shares what informed his approach to money and how the app he co-founded Hugo, attempts to take the fear out of managing money.
|
|
|
|
20:35
|
SEP 22, 2021
22/09/21 - How is our experience of travel expected to change? Insights from The Travel Corp and the World Travel and Tourism CouncilMichelle Martin and Nicholas Lim, Asia CEO of The Travel Corporation discuss the changes for travellers in the new age of travel, working with the World Travel and Tourism Council to get procedures in place and support for travellers.
|
|
|
|
|
13:05
|
SEP 22, 2021
22/09/21 - Evergrande's ongoing debt saga, US FED's September meeting, Johnson and Johnson's vaccine efficacy, Biolidics' ClearEpi NAB test product, Singapore's bonds issue and APAC markets in early tradeWe cover the latest development in the China's Evergrande default story, what investors will to look out for when Jermone Powell speaks at the FOMC meeting today and what catalyst listed Biolodics test product will be able to do.
Michelle Martin and Ryan Huang go beyond the news headlines in this edition of Market View.
|
|
|
|
|
17:09
|
SEP 22, 2021
22/09/21 - Market View Minutes: Cathie Woods' latest purchasesOn Market View Minutes, Michelle Martin discusses Cathie Wood's purchase of biotech companies as she buys the dip.
|
|
|
|
|
02:42
|
SEP 21, 2021
21/09/21 - China’s Evergrande Group, Hong Kong’s strong property counters, investors selling commodities, Pfizer says vaccine safe for kids, Biden easing travel rules, Singapore’s possible travel changes and CapitaLand Investment begins tradingWhat are the fears that an Evergrande default could spill into local markets? Is there a COVID-19 vaccine that is safe for children?
What has been the impact of a US debt ceiling on markets?
Michelle Martin and Ryan Huang go beyond the headlines in this edition of Market View.
|
|
|
|
|
18:47
|
SEP 21, 2021
21/09/21 - China's Evergrande Group property and the spillover in the property market, breaking down what CapitaLand Invest means for the investor and global REITs to watchHow diversified is CapitaLand Invest's portfolio? Will we see more of REIM's list? Are there buying opportunities in the S-REIT market with Covid cases on the uptick?
Michelle Martin finds out with Kenny Loh, REIT Specialist and Independent Financial Advisor.
|
|
|
|
|
14:38
|
SEP 21, 2021
21/09/21 - Market View Minutes: When we see broad based selling, where are the buying opportunities?Michelle Martin discusses the potential buying opportunity of the sell-off and a contrarian view of the passing of the 3.5 trillion dollar US infrastructure package that could benefit some investors.
|
|
|
|
|
02:15
|
SEP 20, 2021
20/09/21 - Investing for Millennials by MillennialsWhat are millennial-driven investment trends? What’s hot and what’s not right now when we look at tech counters in the US and China ?
Michelle Martin speaks with Tim Phillips, Head of Content & Investment Lead @ ProsperUs by CGS-CIMB Securities to find out how millennials are making today’s investment decisions.
|
|
|
|
|
28:11
|
SEP 20, 2021
20/09/21 - What does China's Evergrande debt crunch mean for investors, FOMC's open market committee, Pfizer's vaccine efficacy waning, Singapore market reaction to COVID-19, Hong Kong's latest SPAC rules and SG shares in early tradeIs China's Evergrande too big to fail and what does Evergrande's debt crunch mean for investors? What are the changing regulations by the US' FDA for Pfizer booster shots?
What do you think of Hong Kong's SPAC listings?
Michelle Martin and Ryan Huang go beyond the headlines and market buzz in this edition of Market View.
|
|
|
|
|
16:38
|
SEP 20, 2021
20/09/21 - Market View Minutes with Michelle Martin: A COVID-19 pillOn Market View Minutes, Michelle Martin looks at the next generation of potential COVID-19 treatment and the companies that stand to gain from producing the pill namely, Merck, Pfizer and Atea Pharmaceuticals.
|
|
|
|
|
02:15
|
